One of Compass’ psilocybin treatment rooms
(Picture: Compass )Scientists in London will launch a potentially “game-changing” clinical trial to assess whether the psychedelic compound found in magic mushrooms could help to treat anorexia nervosa.
The phase II clinical trial, involving scientists from King’s College London (KCL) and three US-based research institutes, will examine whether psilocybin can help to alleviate symptoms of the eating disorder.
